Miriam Koopman
A complete genetic analysis should be part of the standard diagnostics for every patient with cancer who is eligible for treatment. WGS contributes to better, coordinated treatment advice. In this way, we reduce over- and under-treatment, while making healthcare more cost-effective and keeping it affordable.
Back to newsMore news
Accreditation renewed
In October 2020, we received formal notification of the renewal of our accreditation of ISO17025: 2005 into the 2017 version. We …
Broader Testing in AYAs Helps
PhD candidates Jeffrey van Putten and Lina Lankhorst investigated whether AYAs (adolescents and young adults, diagnosed with cancer between the ages of …
Healthcare providers share insights about GENAYA for young adult cancer patients
In a series of short videos, our specialists share their insights on the GENAYA project. They explain what GENAYA is, …
A complete genetic analysis should be part of the standard diagnostics for every patient with cancer who is eligible for treatment. WGS contributes to better, coordinated treatment advice. In this way, we reduce over- and under-treatment, while making healthcare more cost-effective and keeping it affordable.